###begin article-title 0
###xml 107 113 107 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
Disease mechanism for retinitis pigmentosa (RP11) caused by missense mutations in the splicing factor gene PRPF31
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 154 160 154 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
Missense mutations in the splicing factor gene PRPF31 cause a dominant form of retinitis pigmentosa (RP11) with reduced penetrance. Missense mutations in PRPF31 have previously been shown to cause reduced protein solubility, suggesting insufficiency of functional protein as the disease mechanism. Here we examine in further detail the effect of the A216P mutation on splicing function.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 100 103 100 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAT1</italic>
Splicing activity was assayed using an in vivo assay in transfected mammalian cells with rhodopsin (RHO) and transducin (GNAT1) splicing templates. Pull-down assays were used to study the interaction between PRPF31 and one of its cognate partners in the spliceosome, PRPF6.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 12 15 12 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAT1</italic>
###xml 159 162 159 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 346 351 346 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAT1</italic>
###xml 393 396 393 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 467 470 467 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 513 518 <span type="species:ncbi:9606">human</span>
Splicing of RHO intron 3 and GNAT1 introns 3-5 mini-gene templates was inefficient with both spliced and unspliced products clearly detected. Assays using the RHO minigene template revealed a direct negative effect on splicing efficiency of the mutant. However, no effect of the mutation on splicing efficiency could be detected using the longer GNAT1 minigene template or using a full-length RHO transcript, splicing of which had an efficiency of 100%. No unspliced RHO transcripts could be detected in RNA from human retina. Pull-down assays between PRPF31 and PRPF6 proteins showed a stronger interaction for the mutant than wild type, suggesting a mechanism for the negative effect.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
Splicing of full-length RHO is more efficient than splicing of the minigene, and assays using a full-length template more accurately mimic splicing in photoreceptors. The RP11 missense mutations exert their pathology mainly via a mechanism based on protein insufficiency due to protein insolubility, but there is also a minor direct negative effect on function.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 558 559 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 770 773 770 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RP9</italic>
###xml 782 783 782 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 793 800 793 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31,</italic>
###xml 808 809 808 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 819 825 819 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF8,</italic>
###xml 833 834 833 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 848 853 848 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF3</italic>
###xml 862 863 862 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
Retinitis pigmentosa (RP) represents a large, heterogeneous group of generally progressive retinal diseases that initially affect the rod photoreceptors but subsequently involve both peripheral and central cones, frequently leading to total blindness. With an incidence of 1 in 3,500 of the population, inheritance may be X-linked, autosomal dominant, or autosomal recessive. In many cases, the disease gene encodes a component of phototransduction or allied processes with expression confined to the retina, for example the rod visual pigment (reviewed in [1]), or peripherin-RDS [2], but not all RP genes show such a restricted pattern of expression. In particular, mutations in four RNA splicing factor genes underlie some autosomal dominant forms of RP, namely RP9 (RP9, OMIM  [3]), RP11 (PRPF31, OMIM  [4]), RP13 (PRPF8, OMIM  [5]), and RP18 (PRPF3, OMIM  [6]). An intriguing aspect to the association of these genes with retinal disease is that splicing occurs in every cell of the body so the genes must have a general housekeeping function, yet the disease pathology is restricted to the rod photoreceptors of the retina.
###end p 11
###begin p 12
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 182 183 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 184 185 184 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 212 223 212 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RP9, PRPF3,</italic>
###xml 228 233 228 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF8</italic>
###xml 268 274 268 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 431 437 431 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
Mutations in PRPF31 are one of the most common causes of autosomal dominant RP, with over 30 mutations reported, including missense, deletion, insertion and splice site alterations [4,7-11]. Whereas mutations in RP9, PRPF3, and PRPF8 are fully penetrant, mutations in PRPF31 are not, with several heterozygous carriers showing no deleterious visual symptoms and only slightly abnormal electroretinograms [12]. Studies conducted on PRPF31 mRNA levels in lymphoblast cell lines isolated from family members with either deletion or splice site mutations indicate that penetrance requires the co-inheritance of a low expressing wild-type (WT) allele alongside the mutant allele [13,14], whereas the presence of a high expressing WT allele is protective. The disease phenotype would appear to arise therefore only when the level of WT splicing factor falls below a critical threshold in rod photoreceptors.
###end p 12
###begin p 13
###xml 19 21 19 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 22 24 22 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 496 502 496 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRP31p</italic>
###xml 986 988 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 1248 1250 1248 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 356 361 <span type="species:ncbi:4932">yeast</span>
###xml 451 456 <span type="species:ncbi:9606">human</span>
###xml 481 486 <span type="species:ncbi:4932">yeast</span>
###xml 730 735 <span type="species:ncbi:4932">yeast</span>
Our previous work [15,16] has investigated the functional consequences of missense mutations in PRPF31 [4]. With missense mutations, the mutant protein is almost certainly produced so the simple answer that the disease arises solely from a haploinsufficiency of splicing factor protein may not provide a full explanation for the disease mechanism. Using a yeast complementation assay, we have previously demonstrated [15] that the introduction of the human A216P mutation into the yeast ortholog PRP31p results in reduced growth; the effect of the mutation would appear to be therefore to modify or reduce the activity of the protein rather than to abolish it completely. In addition, the mutant protein appears to be nontoxic in yeast even when highly expressed. Protein localization studies in mammalian cells expressing His-tagged PRPF31 showed mislocalization of the mutant proteins, with a substantial proportion remaining in the cytoplasm rather than translocated to the nucleus [15]. Further investigations revealed that this mislocalization was unlikely to arise from a deficiency in trafficking of the mutant proteins to the nucleus, but arose rather from an increased tendency for the mutant proteins to form aggregates in the cytoplasm [16]. The consequence of this is a reduction in the levels of PRPF31in the nucleus: an insufficiency of functional protein in the nucleus may be therefore the primary cause of the disease.
###end p 13
###begin p 14
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 304 310 304 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 434 437 434 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 452 455 452 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RDS</italic>
###xml 472 477 472 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN2</italic>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 74 80 <span type="species:ncbi:9913">bovine</span>
###xml 374 379 <span type="species:ncbi:9606">human</span>
###xml 417 422 <span type="species:ncbi:9606">human</span>
Our original in vivo assays of splicing function in HEK 293 cells using a bovine rod opsin splicing template failed to detect any effect of missense mutations on splicing efficiency [15]. However, Yuan et al. [17] and Mordes et al. [18] have shown a specific negative effect of two deletion mutations of PRPF31 on the efficiency of splicing of certain introns in artificial human minigenes, in particular intron 3 of human rod opsin (RHO), intron 1 of RDS and intron 3 of FSCN2. Another study by Rivolta et al. [13] failed however to find any evidence for a generalized RNA splicing defect caused by various null-type mutations.
###end p 14
###begin p 15
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
All four splicing genes linked to autosomal dominant RP encode protein factors required for the formation of stable U4/U6 snRNPs and for assembly of the U4/U6+U5 tri-snRNP. Binding of this tri-snRNP to the presplicing complex represents a key step in the formation of the spliceosome proper. PRPF31 binds to the U4 snRNP in the U4/U6 di-snRNP [19,20] and is thought to form a bridge between the U4/U6 di-snRNP and U5 by binding to the U5-specific PRPF6 (also known as U5-102 kD protein) [21]. This was confirmed by RNAi studies in which it was shown that knock-down of either PRPF31 or PRPF6 inhibited tri-snRNP formation and led to the accumulation of U5 and U4/U6 [22].
###end p 15
###begin p 16
###xml 114 120 114 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 164 167 164 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 294 297 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 366 371 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAT1</italic>
###xml 288 293 <span type="species:ncbi:9606">human</span>
In this study, we have refined our splicing assay system to examine the effects of the A216P missense mutation in PRPF31 on several splicing templates that include RHO intron 3 in a minigene construct plus two templates that more accurately reflect the real life situation, a full-length human RHO gene that includes introns 1-4, and a partial rod alpha-transducin (GNAT1) gene with introns 2-5. Since any direct effect of splicing factor mutations on splicing efficiency would most likely act via interactions with other components of the spliceosome, we have examined the interaction via pull-down assays of WT and mutant PRPF31 with PRPF6, the other protein component of the tri-snRNP not yet implicated in RP.
###end p 16
###begin title 17
Methods
###end title 17
###begin title 18
Plasmid constructs for splicing assays
###end title 18
###begin p 19
###xml 87 90 87 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 134 137 134 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nhe</italic>
###xml 144 147 144 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cla</italic>
###xml 478 484 478 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 584 587 584 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sac</italic>
###xml 590 593 590 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 641 644 641 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">His</sup>
###xml 645 648 645 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 734 737 734 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 832 838 832 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 983 986 983 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sac</italic>
###xml 989 992 989 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 1014 1017 1014 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 81 86 <span type="species:ncbi:9606">human</span>
###xml 110 115 <span type="species:ncbi:9606">human</span>
###xml 317 343 <span type="species:ncbi:311400">Thermococcus kodakaraensis</span>
For the rod opsin minigene assays, an exon 3 to exon 4 fragment (E3-E4) from the human RHO was amplified from human genomic DNA using NheI- and ClaI-tagged forward and reverse primers (5'-GCC GGC TAG CAT GTA CAT CCC CGA GGG CCT G-3' and 5'-CGG CAT CGA TTC ACT TGT TCA TCA TGA TAT AGA TGA C-3', respectively) and KOD (Thermococcus kodakaraensis) polymerase (Novagen, Nottingham, UK). This was cloned into the vector pTandem-1 (Novagen) via the appropriate restriction sites. The PRPF31 cDNA sequence (WT or A216P) was then transferred from a corresponding pTriEx-1 construct [15] as a SacII-XhoI fragment to generate the construct pTan.PRPF31His.RHO E3-4, which expresses both His-tagged PRPF31 protein and an RNA splicing template of RHO E3-4. Corresponding constructs expressing untagged PRPF31 were generated by first cloning the PRPF31 cDNA sequence into the vector pTriEx-1 (Novagen) with a stop codon inserted before the His-tag sequence and then transferring the sequence as a SacII-XhoI fragment into pTan. RHO E3-E4 as previously described.
###end p 19
###begin p 20
###xml 12 15 12 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 120 123 120 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 196 199 196 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 264 267 264 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nhe</italic>
###xml 276 279 276 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nae</italic>
###xml 305 308 305 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nae</italic>
###xml 317 320 317 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cla</italic>
###xml 333 338 <span type="species:ncbi:9606">human</span>
Full-length RHO constructs were generated in a stepwise process because of the relatively large size of the full length RHO gene of 4.985 kb (from start to stop codons and including introns). The RHO sequence was amplified as two separate fragments (E1-E2 with 5'-NheI and 3'-NaeI tags and E2 -E5 with 5'-NaeI and 3'-ClaI tags) from human genomic DNA using the following primer pairs: E1F (5'-GCG CGC TAG CAT GAA TGG CAC AGA AGG CCC T-3') and E2R (5'-GGA CCA GCC GGC GAG TGG-3'); and E2F (5'-CCA CTC GCC GGC TGG TCC-3') and E5R (5'-CGG CAT CGA TTT AGG CCG GGG CCA CCT G-3'). These two fragments were cloned into the PCR vector pGEM-T Easy (Promega, Southampton, UK). Restriction cloning was then used to ligate the fragments together and transfer the assembled gene sequence into NheI/ClaI-cut pTandem-1. The PRPF31 sequence was inserted as before.
###end p 20
###begin p 21
###xml 6 11 6 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAT1</italic>
###xml 64 70 64 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 178 183 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAT1</italic>
###xml 232 235 232 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hpa</italic>
###xml 242 245 242 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cla</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 208 213 <span type="species:ncbi:9606">human</span>
Human GNAT1 constructs were generated by first transferring the PRPF31 cDNA sequence into pTandem-1 as described in the previous paragraph and then inserting an exon 2 to exon 6 GNAT1 fragment amplified from human genomic DNA using HpaI- and ClaI-tagged forward and reverse primers respectively (E2F: 5'-GTT AAC ATG GCC GGT GAG TCC-3' and E6R: 5'-ATC GAT TCA CAC TAG CAC CAT-3').
###end p 21
###begin p 22
###xml 94 97 94 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 135 138 135 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 223 226 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 263 269 263 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 878 881 878 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 886 889 886 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 1055 1060 1055 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAT1</italic>
###xml 1025 1030 <span type="species:ncbi:9606">human</span>
Splicing assays of wild-type and mutant PRPF31 in transfected HEK 293T cells. A: Assays using RHO intron 3 minigene splicing template (RHO-MG). As a positive control, cells were transfected with the splicing template only (RHO-MG only). Cells transfected with WT PRPF31 only gave no products (negative control). Marker for the unspliced product was generated by amplification directly from the plasmid construct using the same primers. B: Bar graphs show the splicing efficiencies, derived from the relative band strengths for cells expressing untagged and His-tagged PRPF31. Error bars indicate the standard error of means derived from four separate determinations. Double asterisks (**) indicate that the reduced splicing efficiencies of mutant splicing factor compared to the positive and negative controls are statistically significant (p<0.01). C: Assays using full length RHO (FL-RHO) splicing template. Analysis of all four introns indicates 100% splicing efficiency. No unspliced transcript was detected in cDNA from human retina. D: Assays using GNAT1 template.
###end p 22
###begin title 23
Plasmid constructs for protein expression
###end title 23
###begin p 24
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF6</italic>
###xml 333 336 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 343 346 343 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sal</italic>
###xml 179 184 <span type="species:ncbi:9606">human</span>
###xml 211 216 <span type="species:ncbi:9606">human</span>
The N-terminal domain (PRPF6N, residues 1-307) and two HAT-containing (half a tetratricopeptide repeat, TPR) domains (PRPF6-M, residues 307-607, and PRPF6-C, residues 607-941) of human PRPF6 were amplified from human cDNA and inserted into the bacterial expression vector pGEX6P-1 (Amersham Biosciences, Little Chalfont, UK) via the EcoRI and SalI sites. The primer pairs used for the amplifications were as follows: for PRPF6N, 5'-GCG CGA ATT CAT GAA CAA GAA CAA ACC GTT CC-3' and 5'-CAG CGT CGA CTG TCA ATG AGG GTT CGT CTC CCG-3'; for PRPF6M, 5'-GCG CGA ATT CCC CCG CCA GCC TGG ATT GCA TC-3' and 5'-CAG CGT CGA CTC ATG CTT TGG GGC AGT CGG C-3'; and for PRPF6C, 5'-GCG CGA ATT CCC CGC CAG CCT GGA TTG CAT C-3' and 5'-GAC GGT CGA CTC AGA AGG TGT TCT TGA TGC G-3'.
###end p 24
###begin title 25
In vivo splicing assays in HEK 293T cells
###end title 25
###begin p 26
###xml 203 206 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 231 234 231 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAT1</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 860 886 <span type="species:ncbi:11866">avian myeloblastosis virus</span>
###xml 888 891 <span type="species:ncbi:11866?0.5863095238095238">AMV</span>
Human HEK 293T cells in 3.5 cm dishes were transiently transfected using GeneJuice (Novagen) with pTandem-1 constructs which expressed PRPF31 (WT or mutant) and a splicing template comprising either the RHO intron 3 mini-gene, the RHO full length gene, or the GNAT1 partial gene. After 48 h, cells were washed twice with PBS and used to prepare total cell RNA using TRIzol reagent (Invitrogen, Paisley, UK). Contaminating DNA carried over from the cell transfection was removed from the extracted RNA by treatment with RNase-free DNaseI (Roche Diagnostics Ltd., Paisley, UK). The RNA was quantified using Quant-iT RiboGreen RNA assay (Invitrogen). RT-PCR was then conducted as follows to assay the relative quantities of spliced and unspliced transcripts from the splicing template. First strand cDNA synthesis was performed with 0.5 microg of total RNA using avian myeloblastosis virus (AMV) reverse transcriptase and oligo-p(dT)15 primer (Roche Diagnostics Ltd). This cDNA was diluted to a total volume of 50 microl, and 5 microl aliquots were used as template in PCR reactions with exonic primer pairs to amplify across the intervening introns. Thermocycling was conducted for the minimum number of cycles (generally 20-25 cycles) to ensure amplification of target sequence remained in the exponential phase. PCR products were analyzed on SYBR Green- (Invitrogen Ltd) or ethidium bromide-stained agarose gels. Relative band strengths were quantified using Genesnap software (Syngene, Cambridge, UK) from gel images.
###end p 26
###begin title 27
Pull-down assays
###end title 27
###begin p 28
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 77 84 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
WT and A216P His-tagged PRPF31 were expressed from pTriEx constructs [15] in E. coli Tuner (DE3) pLacI cells (Merck Biosciences Ltd., Nottingham, UK), purified to homogeneity from inclusion bodies under denaturing conditions and subsequently refolded (as described in [16]). Protein concentrations were estimated using a Biorad protein assay kit (Bio-Rad UK Ltd., Hemel Hempstead, UK) against BSA standards.
###end p 28
###begin p 29
###xml 114 121 114 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 114 126 <span type="species:ncbi:511693">E. coli BL21</span>
Glutathione S transferase (GST)-tagged PRPF6 domains (PRP6F-N, -M, -C) were expressed from pGEX6P-1 constructs in E. coli BL21 (DE3) cells (Amersham Biosciences). Liquid cultures (Luria-Bertani broth with 100 mug/ml ampicilin) were grown at 37 degreesC to log phase, induced with 0.1 mM Isopropyl-Beta-D-Thiogalactopyranoside and then grown overnight at 25 degreesC. Cells were harvested as cell pellets from 20 ml aliquots and soluble extracts containing 1 ml GST-tagged PRP6F-N, PRP6F-M, or PRP6F-C were prepared in PBS buffer by centrifugation of crude cell lysates.
###end p 29
###begin p 30
###xml 737 742 <span type="species:ncbi:10090">mouse</span>
A 100 microl aliquot of GST-tagged PRPF6-N, PRP6F-M, or PRP6F-C extract was first bound to 20 microl of 50% glutathione sepharose beads (Amersham Biosciences) in PBS. Excess PRPF6 was removed, and the beads were washed once with PBS and 0.1 nmol of purified His-tagged PRPF31 was added to give a total volume of 200 mul. The mixture was agitated for 30 min at 4 degreesC. The beads were then centrifuged and washed three times with chilled PBS. Bound proteins were eluted with 2 x 10 microl aliquots of reduced glutathione buffer. These were analyzed on duplicate western blots, one probed with Penta-His antibodies (Qiagen Ltd, Crawley, UK) and the second with anti-GST antibodies (Merck Biosciences) followed by an HRP-conjugated anti-mouse secondary antibody (Perbio Science UK Ltd., Cramlington, UK). Blots were developed with ECL-Plus HRP detection system (Amersham Biosciences). Relative band strengths were quantified using Genesnap software as described in the previous section. Band quantities were normalized to the strength of the WT band for each determination. Mean values were estimated from four independent determinations.
###end p 30
###begin title 31
Results
###end title 31
###begin title 32
Functional assays of splicing activity
###end title 32
###begin p 33
Splicing assays were designed to examine the efficiency of splicing in transfected HEK 293T cells expressing either WT or mutant PRPF31 protein exogenously. These cells also express WT PRPF31 (as well as all the other components of the spliceosome) endogenously. The rationale of the experiment is that the high level of expression of the exogenous splicing factor will compete with the endogenous splicing factor for incorporation into the spliceosome and thus reveal any deleterious effects of the mutations. However, this means that the assays can detect only dominant effects of the mutations and not effects due to insufficiency.
###end p 33
###begin p 34
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
Assays were conducted by transiently expressing PRPF31 protein (WT or mutant) plus a splicing template in HEK 293T cells, extracting total RNA from the cells, and performing RT-PCR to determine the relative quantities of spliced and unspliced RNA products derived from the exogenous splicing template. Previous assays of PRPF31 splicing activity have relied on cotransfection of the cells with two plasmids: one expressing the splicing template and the other PRPF31 [15,17]. This has the drawback that an undefined proportion of the transfected cells will have taken up the splicing template plasmid alone, giving rise to a background of RNA products that have been spliced using only endogenous WT PRPF31. To ensure that all cells expressing the splicing template were also expressing the exogenous PRPF31, plasmid constructs were generated in the pTandem-1 mammalian dual expression vector, which is designed for the coexpression of two open reading frames from a single bicistronic RNA.
###end p 34
###begin title 35
###xml 24 29 <span type="species:ncbi:9606">human</span>
Splicing assays using a human rod opsin RHO intron 3 minigene
###end title 35
###begin p 36
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 123 126 123 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 369 378 369 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 819 828 819 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 915 924 915 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 1097 1106 1095 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B</xref>
###xml 147 152 <span type="species:ncbi:9606">human</span>
A minigene similar to that described by Yuan et al. [17] was constructed that contained a 522 bp sequence amplified across RHO exon 3 to exon 4 of human genomic DNA. When pTandem constructs containing this minigene were used to transfect HEK 293T cells, both spliced (406 bp) and unspliced (522 bp) products were generated, indicating inefficient splicing of intron 3 (Figure 1A, lane 4). The splicing efficiency was estimated as the ratio of band fluorescence (after staining with ethidium bromide) for spliced versus total (spliced + unspliced) transcript, with a correction for the relative fluorescence of different size fragments. Splicing efficiency measured in control cells expressing the minigene only, where only the endogenous splicing factor is present, was not affected by addition of exogenous WT PRPF31 (Figure 1A, lane 2), but splicing efficiency was reduced by the presence of A216P mutant PRPF31 (Figure 1A, lane 3). The means+/-standard error of measurements obtained from four replicate transfections for each experiment with either untagged and His-tagged PRPF31 are shown in Figure 1B. For untagged and tagged PRPF31, therefore, the overall levels of splicing efficiency are similar, indicating that the presence of a His-tag on the exogenous PRPF31 does not affect its splicing function. In both cases, mutant PRPF31 resulted in a statistically significant (p<0.01) reduction in splicing compared to the positive and negative controls..
###end p 36
###begin p 37
Pull-down assays showing the interaction of His-tagged PRPF31 (WT and A216P mutant) with GST-tagged PRPF6 domains. Complexes between the two proteins were immobilized with glutathione sepharose beads and eluted with reduced glutathione. Panels show the Western analysis of elution products using immobilized GST-PRPF6N (amino acids 1-306), GST-PRPF6M (amino acids 307-607), and GST-PRPF6C (amino acids 607-941). Upper panels were probed with alpha-His.tag antibody and lower panels with alpha-GST antibody. Asterisks (*) indicate the size of full-length GST-PRPF6N, GST-PRPF6M, and GST-PRPF6C respectively. Note that the faint band in the upper panel for the pull-down assay with GST-PRPF6N is too small for PRPF31-His. Negative controls show absence of nonspecific binding of His-tagged PRPF31 to the beads and to GST tag. Quantification of the WT and mutant PRPF31 bands gave ratios of mutant:WT of 4.2+/-1.4 (for PRPF6M) and 2.1+/-0.5 (for PRPF6C). In each case, the mean and standard error was determined from four separate determinations.
###end p 37
###begin title 38
###xml 34 39 <span type="species:ncbi:9606">human</span>
Splicing assays using full-length human rod opsin template
###end title 38
###begin p 39
###xml 176 179 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 584 593 584 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1C</xref>
To ascertain how closely the splicing of a minigene approximates to the splicing of a real pre-mRNA template, we generated transfection constructs that expressed a full-length RHO gene from the start to stop codons and included all four introns. RT-PCR was then performed on RNA from transfected cells using primer pairs designed to amplify each intron separately. In contrast to the result with the minigene, the efficiency of splicing of intron 3 with WT exogenous splicing factor was substantially greater, approaching a ratio of 1 for spliced template compared to total template (Figure 1C). When the A216P mutant PRPF31 was used, there was no reduction in splicing efficiency. Results for introns 1, 2, and 4 similarly showed that the cells were able to splice these introns completely even in the presence of mutant PRPF31.
###end p 39
###begin title 40
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
Splicing efficiency of human rod opsin intron 3 in human retinal tissue
###end title 40
###begin p 41
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 106 109 106 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 235 238 235 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 306 315 306 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1C</xref>
###xml 400 403 400 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 272 277 <span type="species:ncbi:9606">human</span>
To assess whether the splicing of RHO intron 3 was a limiting factor in the production of fully processed RHO mRNA in photoreceptors, we generated PCR-amplified fragments using an exon 3 forward and exon 4 reverse primer pair from the RHO transcript in mRNA obtained from human retinal tissue. As shown in Figure 1C, no unspliced product was obtained, similar to our experiments with the full-length RHO template, indicating that the latter splicing assays may model the situation in rod photoreceptor cells more closely than assays with minigenes.
###end p 41
###begin title 42
Splicing assays using partial GNAT1 template
###end title 42
###begin p 43
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAT1</italic>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAT1</italic>
###xml 608 617 608 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1D</xref>
###xml 103 108 <span type="species:ncbi:9606">human</span>
It has been suggested that small introns may be spliced less efficiently than larger introns [17]. The human GNAT1 gene has several small introns of lengths between 89 and 210 bp. We therefore generated splicing constructs containing a partial gene of GNAT1 that comprised exons 2 to 6 and intervening introns, representing approximately one-third of the genomic sequence. Splicing assays using these constructs indicated that introns 3 and 5 are inefficiently spliced. However, no difference in splicing efficiency was detected when WT or A216P mutant PRPF31 was co-expressed (results for intron 3 shown in Figure 1D).
###end p 43
###begin p 44
Role of PRPF31 in pre-mRNA splicing. PRPF31 is a splicing factor specific to the U4/U6 snRNP, and its primary role is to recruit and physically tether U5 to U4/U6 to yield the U4/U6+U5 tri-snRNP. This involves an interaction between PRPF31 and the U5-specific splicing factor PRPF6. Once incorporated into the spliceosomal complex B, activation involves loss of U1 and U4 and all tri-snRNP associated proteins, including PRPF31 and PRPF6. The mutant PRPF31 proteins are predicted to inhibit this activation step (marked with crosses) and prevent recycling of spliceosomal components for future splicing events.
###end p 44
###begin title 45
Interaction of wild-type and mutant PRPF31 with PRPF6
###end title 45
###begin p 46
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 214 219 <span type="species:ncbi:4932">yeast</span>
Formation of the U4/U6+U5 tri-snRNP component of the spliceosome involves an interaction between PRPF31 (a component of U4/U6) and PRPF6 (a component of U5) as demonstrated by biochemical pull-down experiments and yeast two-hybrid studies [21,23]. The PRPF6 protein contains an N-terminal domain followed by several repeat motifs of loose consensus classified as HAT domains, a feature present in many RNA binding proteins [24]. Pfam analysis [25] identified 9 such motifs. The interaction of PRPF6 with PRPF31 was initially reported to involve the C-terminal HAT repeats only [21] but has more recently been shown to involve other HAT repeats [23].
###end p 46
###begin p 47
###xml 389 398 389 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2A</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 650 659 650 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2B</xref>
In this study, we expressed PRPF6 protein as three separate domains comprising residues 1-307 (PRPF6N), 307-607 (PRPF6M, HAT domains 1-5 according to Pfam analysis) and 607-941 (PRPF6C, HAT domains 6-9 according to Pfam analysis), together with N-terminal GST tags. Pull-down experiments with His-tagged WT PRPF31 indicated interactions with PRPF6M as well as PRPF6C, but not with PRPF6N (Figure 2A), confirming previous results [21,23]. Quantitative experiments using equivalent quantities of purified WT and mutant PRPF31 proteins indicated that the interaction of both PRPF6M and PRPF6C was substantially stronger with mutant than with WT PRPF31 (Figure 2B).
###end p 47
###begin title 48
Discussion
###end title 48
###begin p 49
###xml 84 90 84 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 144 147 144 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 555 563 <span type="species:ncbi:9606">patients</span>
The results presented in this study demonstrate that the A216P missense mutation in PRPF31 has a dominant deleterious effect on the splicing of RHO intron 3 transcribed from a minigene in transfected mammalian cells. Using a similar minigene assay, Yuan et al. [17] reported a comparable deleterious effect in cells expressing truncated PRPF31 proteins based on two pathogenic frameshift mutations (RP11 families SP117 and AD5 [4]). However, unlike the missense mutations, where mutant proteins will almost certainly be expressed in the cells of affected patients, such truncated proteins may either be rapidly degraded or not produced due to nonsense mediated decay (NMD). This latter process results in the rapid removal of mutant transcripts that contain a premature termination codon (reviewed in [26]).
###end p 49
###begin p 50
###xml 659 667 659 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
The results of the pull-down assays described here provide a possible explanation for the dominant deleterious effect of the missense mutation on function. Our results show that the A216P mutation results in a stronger interaction between the PRPF31 and HAT-motifs in PRPF6. This will stabilize the U4/U6+U5 snRNP and should promote the formation of splicing complex B but could inhibit subsequent protein-RNA movements during the later stages of the splicing cycle. In particular, activation of the spliceosomal complex B is believed to involve extensive remodeling that includes the removal of U4 and all tri-snRNP proteins, including PRPF6 and PRPF31 (see Figure 3, modified from [27]). In effect, once incorporated into a spliceosomal complex, the mutant protein may inhibit its activation for that splicing event and the subsequent recycling of the spliceosomal components for future splicing events.
###end p 50
###begin p 51
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 1458 1460 1458 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
While the observation of a dominant deleterious effect of the A216P missense mutation in PRPF31 could account for the dominant nature of the RP11 form of disease, it fails to offer an explanation for the incomplete penetrance of the disorder in families with obligate carriers of the disease allele. Reduced splicing efficiency could only be detected with minigene transcripts, not full-length transcripts from a complete gene sequence; splicing from a full-length transcript appears to occur therefore with full efficiency in the presence of mutant splicing factor. One possible explanation for this discrepancy is that greater splicing efficiency may be achieved with a full-length transcript, because some intrinsic feature in the RNA facilitates splicing or promotes binding of an extrinsic splicing enhancer. For example, splicing enhancers may show exonic binding (reviewed in [28]) and will not function in a minigene assay. Whatever the mechanism, the assays using the full-length gene construct are more likely to reflect conditions pertaining in photoreceptor cells than those using minigenes. This is not to say that the observed splicing deficiency using the minigene assays is an artifact, rather we suggest that the design of the assay is such as to reveal a rather mild effect of the mutation. Severe RP arises from haploinsufficiency but can be prevented if a high-expressing WT allele is present. Such unaffected carriers of RP11 mutations [29] may nevertheless show a mild retinal pathology that may be attributable to a residual haploinsufficiency. However, it may also arise from a reduction in the efficiency of splicing caused by the mutant PRPF31 protein.
###end p 51
###begin p 52
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAT1</italic>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 465 468 465 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
Our results using the GNAT1 splicing template support previous suggestions that splicing of small introns may be less efficient than splicing of larger ones [17]. Splicing of both introns 3 and 5 was inefficient, even with a transcript containing multiple exons and introns. However, even with these weak introns, our assays failed to detect any effect of the A216P mutation on splicing efficiency. This is consistent therefore with our result with the full-length RHO transcript.
###end p 52
###begin p 53
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 423 429 423 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 556 562 556 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRPF31</italic>
###xml 615 616 615 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1203 1206 1203 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 1229 1234 1229 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNAT1</italic>
Our previous work has shown that another effect of the missense mutations is to reduce protein solubility and cause protein mislocation when expressed in transfected cells [15,16]. This will result in substantially reduced levels of functional PRPF31 in the nucleus, which may in turn lead to an accumulation of unspliced transcripts and aberrant proteins, eventually causing cell death. The pathological mechanism whereby PRPF31 missense mutations result in RP is therefore protein insufficiency, and this may also underlie the disease pathology of other PRPF31 mutations studied to date, including gene deletion [7,10], where no mutant protein can be present, and mutations leading to premature termination where NMD of mutant transcripts occurs [13]. Based on the results presented in this report, we have now found that the missense mutations have a direct effect on splicing efficiency in addition to the proposed more general effect on PRPF31 sufficiency, thereby creating a second mechanism for the pathology. However, it is probable that the specific effect on splicing makes only a minor contribution to the development of the disease, since it could not be detected using either a full-length RHO template or a partial GNAT1 template. The major effect of these mutations remains therefore a reduction in the amount of PRPF31 protein entering the nucleus.
###end p 53
###begin title 54
Acknowledgments
###end title 54
###begin p 55
This work was supported by the British Retinitis Pigmentosa Society and Foundation Fighting Blindness, USA. Some of the data were included in a poster presentation at the 2006 ARVO Conference, Fort Lauderdale, Florida.
###end p 55
###begin title 56
References
###end title 56
###begin article-title 57
Retinitis pigmentosa: defined from a molecular point of view.
###end article-title 57
###begin article-title 58
A three-base-pair deletion in the peripherin-RDS gene in one form of retinitis pigmentosa.
###end article-title 58
###begin article-title 59
PAP-1, the mutated gene underlying the RP9 form of dominant retinitis pigmentosa, is a splicing factor.
###end article-title 59
###begin article-title 60
###xml 2 7 <span type="species:ncbi:9606">human</span>
###xml 19 24 <span type="species:ncbi:4932">yeast</span>
A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11).
###end article-title 60
###begin article-title 61
Mutations in the pre-mRNA splicing factor gene PRPC8 in autosomal dominant retinitis pigmentosa (RP13).
###end article-title 61
###begin article-title 62
Mutations in HPRP3, a third member of pre-mRNA splicing factor genes, implicated in autosomal dominant retinitis pigmentosa.
###end article-title 62
###begin article-title 63
A large deletion in the adRP gene PRPF31: evidence that haploinsufficiency is the cause of disease.
###end article-title 63
###begin article-title 64
Mutations in the pre-mRNA splicing gene, PRPF31, in Japanese families with autosomal dominant retinitis pigmentosa.
###end article-title 64
###begin article-title 65
Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families.
###end article-title 65
###begin article-title 66
Genomic rearrangements of the PRPF31 gene account for 2.5% of autosomal dominant retinitis pigmentosa.
###end article-title 66
###begin article-title 67
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Mutations in the gene coding for the pre-mRNA splicing factor, PRPF31, in patients with autosomal dominant retinitis pigmentosa.
###end article-title 67
###begin article-title 68
Autosomal dominant retinitis pigmentosa with apparent incomplete penetrance: a clinical, electrophysiological, psychophysical, and molecular genetic study.
###end article-title 68
###begin article-title 69
###xml 107 115 <span type="species:ncbi:9606">patients</span>
Variation in retinitis pigmentosa-11 (PRPF31 or RP11) gene expression between symptomatic and asymptomatic patients with dominant RP11 mutations.
###end article-title 69
###begin article-title 70
###xml 29 37 <span type="species:ncbi:9606">patients</span>
Expression of PRPF31 mRNA in patients with autosomal dominant retinitis pigmentosa: a molecular clue for incomplete penetrance?
###end article-title 70
###begin article-title 71
Disease mechanism for retinitis pigmentosa (RP11) caused by mutations in the splicing factor gene PRPF31.
###end article-title 71
###begin article-title 72
A study of the nuclear trafficking of the splicing factor protein PRPF31 linked to autosomal dominant retinitis pigmentosa (ADRP).
###end article-title 72
###begin article-title 73
Mutations in PRPF31 inhibit pre-mRNA splicing of rhodopsin gene and cause apoptosis of retinal cells.
###end article-title 73
###begin article-title 74
Identification of photoreceptor genes affected by PRPF31 mutations associated with autosomal dominant retinitis pigmentosa.
###end article-title 74
###begin article-title 75
Hierarchical, clustered protein interactions with U4/U6 snRNA: a biochemical role for U4/U6 proteins.
###end article-title 75
###begin article-title 76
RNA structural requirements for the association of the spliceosomal hPrp31 protein with the U4 and U4atac small nuclear ribonucleoproteins.
###end article-title 76
###begin article-title 77
Protein 61K, encoded by a gene (PRPF31) linked to autosomal dominant retinitis pigmentosa, is required for U4/U6*U5 tri-snRNP formation and pre-mRNA splicing.
###end article-title 77
###begin article-title 78
RNAi knockdown of hPrp31 leads to an accumulation of U4/U6 di-snRNPs in Cajal bodies.
###end article-title 78
###begin article-title 79
###xml 55 60 <span type="species:ncbi:9606">human</span>
The network of protein-protein interactions within the human U4/U6.U5 tri-snRNP.
###end article-title 79
###begin article-title 80
The HAT helix, a repetitive motif implicated in RNA processing.
###end article-title 80
###begin article-title 81
Pfam: a comprehensive database of protein domain families based on seed alignments.
###end article-title 81
###begin article-title 82
Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species.
###end article-title 82
###begin article-title 83
Small nuclear ribonucleoprotein remodeling during catalytic activation of the spliceosome.
###end article-title 83
###begin article-title 84
Cell signalling and the control of pre-mRNA splicing.
###end article-title 84

